fda approved glp-1 for weight loss The New Management Meds FDA approves Lilly's Foundayo (orforglipron)
Description
RochoJKalinowskiPSzymanek-MajchrzakKGratM

and Li et al
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
10.1016/j.molmet.2017.07.016 87

Current and projected future economic burden of parkinsons disease in the U.S

Up to 40% of the weight lost on GLP-1 medications is lean muscle, not fat
